Metastatic Ablation in Epidermal Growth Factor Receptor Mutated Oligometastatic Non-Small Cell Lung Cancer-Upfront or Outback After Systemic Tyrosine Kinase Inhibitors?
Author(s)
Siva, S; Solomon, BJ;
Details
Publication Year 2023-07-01,Volume 116,Issue #3,Page 481-482
Journal Title
International Journal of Radiation Oncology, Biology, Physics
Publication Type
Commentary
Publisher
Elsevier
Keywords
Humans; *Carcinoma, Non-Small-Cell Lung/genetics/therapy/pathology; *Lung Neoplasms/genetics/pathology; Tyrosine Protein Kinase Inhibitors; Gefitinib; Protein Kinase Inhibitors/therapeutic use/pharmacology; ErbB Receptors/genetics; Mutation
Department(s)
Radiation Oncology; Medical Oncology
PubMed ID
37270244
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2023-10-24 04:47:23
Last Modified: 2024-07-16 04:29:33

© 2024 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙